GRK6 and prostate adenocarcinoma: The 6 prognosis-related genes (CASP8, GRK6, IL3RA, PLCB1, TBKBP1, and TNFSF10) were screened as the most significant indicators, generating the CPRS to assess the patient survival in PRAD (Fig. 4A and B).